Organisation paid for research Program year 2025 Source: CMS Open Payments

TKL Research Inc

Neither a doctor nor a teaching hospital

Research payments

$10,453,664

200 payments

Through program year 2025, TKL Research Inc is reported as receiving $10,453,664 in research payments, across 200 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $718,869 7
2024 Research $1,463,650 55
2023 Research $3,147,049 24
2022 Research $34,908 3
2021 Research $1,327,091 15
2020 Research $1,836,836 61
2019 Research $1,925,261 35

Breakdown

Who paid Research payments · program years 2019–2025
  1. Noven Pharmaceuticals, Inc. $4,195,278 59 payments
  2. Sanofi US Services Inc. $3,244,218 27 payments
  3. Becton, Dickinson and Company $2,007,942 25 payments
  4. C. R. Bard, Inc. & Subsidiaries $473,017 4 payments
  5. Next Science LLC $448,596 42 payments
  6. Davol Inc. $35,775 1 payment
  7. Eli Lilly and Company $34,658 3 payments
  8. Acrotech Biopharma LLC $14,180 39 payments
Studies the money was for Research payments · program years 2019–2025
  1. A Two-part, Randomized Partially-blinded, Parallel-group, Placebo- and Active Comparator-controlled Phase 1 Study to Evaluate the Photosafety of Repeated Oral Dose of SAR441566 in Healthy Adult Participants $3,244,218 27 payments
  2. A Randomized, Evaluator-Blinded Study to Evaluate Skin Irritation and Sensitization of D-Amphetamine Transdermal System (D-Ats) in Healthy Adults $1,370,255 21 payments
  3. An Evaluator-blinded, Randomized Within-subject Repeat Insult Study to Evaluate Potential Skin Irritation and Sensitization of HP-5000 (Diclofenac Sodium Topical System) in Healthy Adults $1,324,215 11 payments
  4. Yoda $1,200,036 10 payments
  5. A Randomized, Single-Dose, Multipart Crossover Study to Determine the Effect of External Heat on the Pharmacokinetics of D-Amphetamine Transdermal System D-Ats and to Compare the Pharmacokinetics of Amphetamine Delivered By D-Ats, Adderall XR and Vyvanse in Healthy Adult Subjects $888,800 17 payments
  6. A Randomized, Evaluator-Blinded Study to Evaluate Skin Irritation and Sensitization of D-Amphetamine Transdermal System D-Ats in Healthy Adults $598,005 6 payments
  7. Swatch $213,072 1 payment
  8. RISE H&H Female External Catheter $200,335 2 payments
  9. PW Adolescent $189,979 1 payment
  10. Pendl02 $143,513 2 payments
What the money was spent on Research payments · program years 2019–2025
  1. Patient care $303,316 13 payments
  2. Non-patient care $78,973 13 payments
  3. Medical research writing or publication $28,250 2 payments
  4. Overhead $23,890 6 payments
  5. Other $14,167 8 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record